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Abstract 
Endoleaks are the most common complications following 
endovascular aneurysm repair. Depending upon their 
origin, there are five types of endoleaks, types I-V, which 
can also be classified as direct and indirect endoleaks. 
Direct endoleaks (type I and III) have higher risk of 
aneurysm rupture due to rapid sac expansion, and require 
immediate correction.  Indirect endoleaks ( type II, IV and 
V) have a relatively benign course compared to direct 
endoleaks. Most of them resolve with time and very few  
need interventions upon sac enlargement. Type V 
endotension is a special situation where there is sac 
enlargement despite no demonstrable endoleak. Proper 
planning and appropriate selection of stent-graft can 
prevent most of these endoleaks. With improvement in 
stent-graft technology, the incidence of endoleaks has 
been reduced. The current narrative review was planned 
to describe the pathophysiology, risk factors and 
treatment options for each type of endoleak. 
Keywords: Endovascular, Endoleak, Embolisation. 
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Introduction 
Endovascular aortic aneurysm repair (EVAR) has become 
the preferred treatment modality for treating aortic 
aneurysms. Endoleaks are the most common 
complication following EVAR, and are regarded as 
treatment failure. They are traditionally divided into five 
types based on their origin (Table). Type I, or 
implantation, endoleaks occur at the stent-graft landing 
sites. These are due to inadequate apposition of stent-
graft with arterial wall. Type II, or backflow, endoleaks are 
due to retrograde filling of the aneurysm cavity from one 
of the branch vessels. Type III, or junction, endoleaks are 
due to extravasation of blood at stent-graft component 
junction points or due to graft fabric tear. Type IV, or 
porosity, endoleaks are due to porosity of the stent-graft. 
Type V is a special situation where there is sac 
enlargement despite no demonstrable endoleak. The 
limitation of this classification is that it does not shed light 
on any urgency of treatment. A more practical way to 
classify endoleaks is to divide them into 'direct' and 
'indirect' endoleaks. Direct endoleaks types I and III 
transmit direct systemic pressure into the aneurysmal 
cavity. Due to this direct pressure, there is always risk of 
rapid aneurysm enlargement and rupture. Therefore, they 
need immediate repair. Indirect endoleaks increase sac 
pressure by an indirect way either through small branches 
or through the graft wall. The sac can increase in size, but 
at a slower rate than direct endoleaks. They have a 
relatively benign course as most resolve with time and 
very few require interventions (Figure-1). 
Best way to detect endoleaks 
Completion angiogram can detect early types I and III 
endoleaks. Delayed images can show type II endoleaks. 
Contrast-enhanced computed tomography (CT) is the 
gold standard for the detection of endoleaks on 
subsequent visits. A complete CT study requires a triple-
phase CT angiography (CTA), also called an angiogram. 
Arterial phase images show types I and III endoleaks, 
images delayed by 2-3 minutes show type II endoleaks, 
and non-contrast-enhanced images show mural calcium, 
which might otherwise be misidentified as contrast-
enhanced blood, or endoleak.  
Duplex ultrasound can also detect an endoleak. It is 
economical, free of radiation and contrast. Besides 
detecting the endoleak, it can also provide information on 
different types of flow and directions in these endoleaks.1 
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Table: Classification of endoleaks. 
 
Type of Endoleak                                                   Description 
 
Type I                                  Failure to achieve adequate seal 
                                              Ia- Proximal Landing site 
                                              Ib- Distal landing site 
                                              Ic- Common Iliac artery 
Type II                                 Backflow of blood from aortic collaterals into the aneurysm sac 
                                              Early —  Occurring within 30 days of  Endovascular aortic 
                                              aneurysm repair (EVAR) 
                                              Late — Occurring after 1 year of EVAR 
                                              Persistant- Present for more than 6 months after EVAR 
Type III                                 Endoleak secondary to structural failure of endograft 
                                              IIIa — Component separation 
                                              IIIb — Stent fabric disturbance 
Type IV                                Related to graft fabric porosity 
Type V (Endotension)     Continued high intra-sac pressure following EVAR without 
                                              evidence of aneurysmal sac perfusion
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Its limitations are that it is operator-dependent. 
Type I implantation endoleaks 
Type I endoleaks are due to poor apposition of stent-graft 
to the arterial wall and occur either at proximal (type Ia) or 
distal (type Ib) sites. They normally occur when an 
unfavourable anatomy, such as hostile aortic neck or 
ectatic iliac artery, is being treated. The persistent flow 
between the graft and arterial wall increases pressure 
within the aneurysm. Most type I endoleaks occur 'early'. 
Due to graft migration or late neck dilation, some patients 
can develop 'late' type 1 endoleaks. 
Early type 1 endoleaks 
Short, angulated, heavily calcified infrarenal neck, and 
neck with thombus are the risk factors for early type Ia 
endoleaks. Currently permitted infrarenal stent-grafts 
mandate minimum neck length of 10-15mm to achieve 
an adequate seal. Depending on the accuracy of stent-
graft placement, a significant length of infrarenal 
coverage can be lost and this may jeopardise the 
endograft seal. 
Late type I endoleaks 
Most cases of late type I endoleaks are those in which 
stent-graft had been placed outside of instructions for use 
(IFU) criteria.2 The presence of hostile neck anatomy 
affects long-term outcome.3 Wide and angulated necks 
and dilated iliac landing zones have a higher risk of 
producing late type I endoleaks.4 It is essential to position 
the stent-graft in healthy landing zones at both proximal 
and distal ends to achieve a good long-term outcome. It 
may mean outspreading the repair across the visceral 
arterial segment and/or prolonging the repair beyond the 
iliac bifurcation, if needed. 
Type I endoleak management 
There are some adjuncts that can be used to treat type I 
endoleaks (Figure-2). 
a. Intraoperative angioplasty 
The first step to treat a proximal type I endoleak is a 
balloon angioplasty with a semi-compliant balloon, like 
Coda (Cook) or Reliant (Medtronic), which passes over a 
stiff wire, such as Lunderqvist (Cook) or Amplants (Cordis). 
Percutaneous transluminal angioplasty (PTA) will 
sometimes align the graft better in an angled neck and/or 
decrease graft infolding and gutters that may arise with 
graft oversizing. If it is unable to correct type I endoleak, 
the aortic cuff can be considered to seal this. 
b. Cuff placement 
The practice for an endograft cuff employment is almost 
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Figure-1: Flow-chart showing timing and approach to different types of endoleaks.
CTA: Computed tomography angiography.
similar to the initial endograft placement. Initial type Ia 
endoleak treatment is predicted on the position of the 
endograft to the lowest renal artery. If the distance is 
<3mm, the seal zone should undergo angioplasty with a 
compliant moulding balloon. If the distance is >5mm, the 
initial placement of an aortic cuff is followed by compliant 
balloon angioplasty. 
If type I endoleak is due to insufficient neck length or 
utilisation of such a neck, proximal cuff extension might 
not be an appropriate option. The problem can be better 
solved by Palmaz stent placement. 
c. Palmaz stent placement 
Various techniques have been described for Palmaz stent 
placement. One of them is described here:  
The first step involves placing a 16F 45cm sheath from the 
groin with it tip positioned above the renal arteries. The 
giant Palmaz stent (40-14) is then crimped onto a Coda 
balloon. By gently dilating the stent with a 14-16F dilator, 
it is easier to fit it onto the balloon. The mounted stent is 
passed through sheath while being careful when pushing 
it through the valve so it does not slip off the balloon. The 
stent is positioned partially across the renal arteries. Since 
the nominal size of the stent is 14mm, it will foreshorten 
significantly when taken up to the size of an endograft. 
Exactly how much it will shorten is sometimes difficult to 
determine precisely. The 16F sheath is retracted so that it 
may cover about 1/3 of the distal end of the stent. The 
balloon is then inflated steadily at a slow pace. Inflating or 
deflating the balloon is done until the stent is fully 
deployed. A slight cranial pressure is also deployed to 
mitigate the 'wind sock' effect.  When the proximal end of 
the stent is deployed against the endograft, an assistant is 
asked to retract the 16F sheath to fully uncover the stent. 
The balloon can be deflated and repositioned to allow for 
further moulding of the stent that is sometime necessary. 
Comparable results have been noted between the 
patients undergoing bare metal stent versus those having 
extension cuff repair.5 
d. EndoAnchors 
The results of Phase I multicentre trial (STAPLE 1) of the 
Aptus endovascular repair system showed the usefulness 
of EndoAnchors in EVAR to aid proximal fixation and 
sealing.6 A study also showed effectiveness of 
EndoAnchors as an adjunct in the treatment of infrarenal 
abdominal aortic aneurysm (AAA) with short neck, and 
pararenal AAA.7 It demonstrated sealing of type 1a 
endoleaks in that case series. When selecting 
EndoAnchors, cost implications of these have to be 
considered. The cost of EndoAnchors can be as high as 
the actual EVAR stent-graft. 
e. Embolisation 
Embolisation in the perigraft space can seal the endoleak 
in 'selected' cases. This option has been shown to be 
effective by using various combinations of coils and 
embolics.8-10 The commonly used agents are N-butyl 
cyano acrylate (NBCA) (Trufill, Cordis, Miami, FL) and Onyx 
(Plymouth, MN). 
f. Other options 
If endovascular manoeuvres fail to improve the seal, 
conventional open surgical repair, banding the neck with 
soft nylon umbilical tape or a segment of Dacron graft 
material, fenestrated endovascular aortic aneurysm repair 
(FEVAR) or leaving the endoleak untreated are some of 
the options. 
Treatment of type Ib endoleak 
Ectatic common iliac arteries up to 2cm in diameter are 
suitable landing zones for the iliac limb of an aortic 
endograft. However, common iliac arteries >2cm 
generally necessitate extension of the endograft to the 
external iliac artery. When extending to the external iliac 
artery, one should be particularly mindful of oversizing, 
which can predispose to limb thrombosis or a type Ib 
endoleak. There is frequently significant iliac tortuosity in 
these cases, which makes accurate length measurements 
difficult. When in doubt, a longer limb length should be 
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Figure-2: Flow-chart showing different options  for treating  type 1 endoleaks.
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chosen for external iliac extension. The internal iliac artery 
should be embolised prior to extending the limb into the 
external iliac artery. 
Type II endoleaks 
Type II endoleaks are due to retrograde filling of the 
aneurysmal sac from either lumbar, inferior mesenteric, 
middle sacral, or aberrant renal arteries. These are the 
most common types of endoleaks with surveillance CT 
scans showing in 10-20% cases. When managing a 
patient with type II endoleaks, questions that come to 
mind are: what is the natural course of these 
endoleaks?; Which patients are more at risk of 
developing type II endoleaks?; What can be the 
strategies to reduce incidences of these endoleaks?; 
Which of the patients with type II endoleaks need 
intervention?; What is the best method to deal with 
'persistant type II endoleak? 
a. Natural course of type 2 endoleaks 
Compared to direct endoleaks, type II endoleaks are 
relatively benign.11 As many as 80% of type 2 endoleaks 
resolve spontaneously within 6 months of the stent-graft 
implantation.12 Those that persist are unlikely to cause 
aneurysm pressurisation, dilatation or rupture.13 There is 
about 1% of aneurysm rupture reported at 2 years in such 
cases.14 
b. Risk factors for type II endoleaks 
Patients with patent inferior mesenteric artery (IMA) and 
lumbar arteries (LA) on the pre-operative CTA are more at 
risk of developing type 2 endoleaks  than patients with 
occluded IMA and LA. Out of the patent arteries, patients 
with IMA >3mm and lumbar arteries >2mm are more at 
risk of developing type 2 endoleaks.15 
It is also important to look for the type of aneurysm. 
Patients with aorto-iliac type aneurysms are more at risk 
of developing this endoleak than patients with saccular 
type aneurysms. 
c. Prevention of type II endoleaks 
Patients with IMA >3mm and LA >2mm can benefit from 
prophylactic embolisation which has been shown to be 
effective in reducing the incidence of endoleaks.16 
d. Indication for intervention for type II endoleaks 
Most type II endoleaks resolve with time. Persistence of 
endoleak itself is not an indication for intervention. 
Indication is warranted in patients where there is 
aneurysmal sac enlargement >5 mm.17,18 
 
e. Treatment of type 2 endoleaks  
Embolisation and occlusion of the feeding arteries is the 
aim whilst treating patients with type II endoleaks. 
Embolisation can be done by either transarterial or 
translumbar route. The sac can be thrombosed by 
injecting various chemicals (Figure-3). 
1. Transarterial embolisation 
Embolisation of the branches may be performed 
through a super-selective catheterisation or a trans-
lumbar approach. Transarterial embolisation is more 
likely to succeed when the endoleak cavity is fed 
through a patent inferior mesenteric artery. It is usually 
possible to pass a microcatheter through the middle 
colic branch of the superior mesenteric artery, around 
the colonic arcade, and through the left colic artery to 
the inferior mesenteric artery. The reported success rate 
is 71.4%.19 
2. Translumbar embolisation 
If transarterial access fails or is not possible, translumbar 
access is the alternative.20 Selective catheterisation is 
performed with coaxial microcatheter systems through 
which mechanical, liquid, or combined embolic agents 
can be delivered.7,21,22 The average success rate after 
translumbar embolisation is 81% (range: 67-100%).23 The 
target of embolisation should be the nidus and the feeder 
branches of the endoleak. 
3. Promotion of thrombus formation 
Aneurysm is lined by thrombus. Promotion of thrombus 
formation inside the aneurysmal sac is considered 
another possible method of preventing type 2 endoleak. 
A study reported coil embolisation, gelform and fibrin 
glue as useful adjuncts in promoting aneurysmal sac 
thrombosis.24 
f. Treatment for persistent type II endoleaks 
If the endoleak persists and the sac continues to grow 
after 'technically' successful embolisations, or when 
embolisation is impossible, more invasive approach is 
required. 
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Figure-3: Flow-chart showing options for treating type 2 endoleaks.
Laparoscopic ligation of the feeding lumbar, IMA and 
other side branches are options.25 Laparotomy and 
suturing of the side branch ostia within the aneurysmal 
sac or conversion to open can be offered in extreme cases. 
Type III endoleaks 
Type III endoleaks are either due to disconnection of 
stent-graft components or due to fabric tear. These 
endoleaks are typically treated by the placement of 
additional stent-graft. 
Component overlap between stent-graft limbs as well as 
between main stent-graft components can readily be 
seen on plain X-ray films of the abdomen. Often, at times, 
radio-opaque markers on the device or the skeletal 
components themselves serve as good landmarks for 
comparison. Changes in overall stent-graft configuration, 
like increased limb or body angulations, often give a 
direct hint that the prosthesis is moving, thus increasing 
the risk of disconnection and endoleaks. 
CT can also be used, but it is more difficult to detect small 
configurational changes and minor graft dislocation. To 
do this, reconstructions that highlight only the stent-graft 
metal components must be used. With modern three-
dimensional (3D) workstations, this can be achieved 
partially or fully automatically. The radiation dose is 
manifold higher with CT and this should be taken into 
consideration. CTA is of course very useful for identifying 
and analysaing the endoleak itself. 
Both in the peri- and post-operative periods, type III 
endoleaks are mostly treated by the placement of new 
stent-graft components in the so-called "relining''. This is 
often quite straightforward as long as total separation has 
not occurred. In very challenging tortuous anatomy, it is 
sometime difficult to place additional main components. 
In such a setting, balloon expandable stent can be used to 
reinforce junctions if complete dislocation has not 
occurred. 
Type IV endoleaks 
Type IV endoleak is due to porosity of stent-graft fabric 
without any signs of tear or erosion. This usually happens 
when the graft material is highly porous. Mostly it resolves 
by itself. This endoleak is typically observed without any 
intervention. With improved quality of graft fabric, the 
incidence of these endoleaks has markedly decreased. 
Type V endotension endoleaks 
Endotension is when there is no demonstrable endoleak, 
but there is sac expansion. Its exact aetiology is not 
known. The treatment is exclusion of any endoleak and 
close surveillance. In case of expanding aneurysm, the 
open conversion and explantation is advised which is a 
major undertaking. The other is a hybrid approach using 
both endovascular and laparoscopic options.  It may 
include laparoscopic clipping of all lumbar arteries, 
placement of a Dacron cuff to seal the neck 
laparoscopically, use of EndoAnchors to help fixate the 
stent-graft, and introducing a thrombotic agent into the 
aneurysmal sac to occlude the cavity. 
Conclusion 
Endoleaks are the most common complications following 
EVAR. Proper planning and appropriate selection of stent-
graft can prevent most of these endoleaks. With 
improvement in stent-graft technology, the incidence of 
endoleaks has been reduced. 
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